GlassScriptPhysician profile
Charles W Rush
NPI 1306884119
$1,132.03
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $250 · 2021: $243 · 2022: $38.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $516.40 | 2019-2021 | |
| Pacira Therapeutics, INC. | $264.92 | 2019-2021 | |
| Stryker Corporation | $231.86 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $76.16 | 2021-2022 | |
| Ermi LLC | $15.45 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.14 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.10 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.